| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| ABBV 艾伯維 | 7,257,000,000.0 | 27,785,000,000.0 | 143,422,000,000.0 |
| AZN AstraZeneca PLC | 4,797,000,000.0 | 24,155,000,000.0 | 104,922,000,000.0 |
| BMY 施貴寶 | 7,890,000,000.0 | 28,075,000,000.0 | 93,670,000,000.0 |
| AMGN 美國安進 | 9,011,000,000.0 | 26,766,000,000.0 | 90,883,000,000.0 |
| GILD 吉利德科學 | 5,037,000,000.0 | 14,779,000,000.0 | 54,525,000,000.0 |
| REGN 雷傑納榮製藥 | 2,011,800,000.0 | 19,333,600,000.0 | 37,441,900,000.0 |
| BIIB Biogen Inc | 1,699,200,000.0 | 6,830,500,000.0 | 28,313,200,000.0 |
| BNTX Biontech SE | 11,139,491,217.0 | 19,625,480,416.0 | 23,872,608,029.0 |
| VRTX 福泰製藥 | 5,239,200,000.0 | 9,804,100,000.0 | 22,240,200,000.0 |
| MRNA 莫德納 | 1,644,000,000.0 | 9,666,000,000.0 | 15,803,000,000.0 |
| SVA Sinovac Biotech Ltd | 1,072,350,000.0 | 11,148,280,000.0 | 12,896,937,000.0 |
| BIO.B Bio Rad Laboratories Inc | 410,377,000.0 | 3,055,620,000.0 | 10,603,472,000.0 |
| BMRN BioMarin Pharmaceutical Inc | 293,667,000.0 | 3,056,590,000.0 | 6,851,195,000.0 |
| EXAS Exact Sciences Corp | 588,830,000.0 | 1,533,117,000.0 | 6,748,571,000.0 |
| QGEN Qiagen NV | 972,985,000.0 | 2,454,073,000.0 | 6,270,197,000.0 |
| ROIV Roivant Sciences Ltd | 1,958,633,000.0 | 5,801,119,000.0 | 6,206,028,000.0 |
| ILMN Illumina Inc | 869,000,000.0 | 2,373,000,000.0 | 6,014,000,000.0 |
| GMAB Genmab A/S | 947,558,220.0 | 3,540,867,590.0 | 5,925,600,600.0 |
| BGNE Beigene Ltd | 2,701,933,000.0 | 3,911,736,000.0 | 5,830,860,000.0 |
| INCY 英賽德 | 1,304,109,000.0 | 2,808,708,000.0 | 5,012,434,000.0 |
| GLPG Galapagos NV | 61,813,200.67 | 3,962,675,598.12 | 4,644,870,764.58 |
| ALNY Alnylam Pharmaceuticals Inc | 1,099,920,000.0 | 3,355,424,000.0 | 4,205,039,000.0 |
| SRPT Sarepta Therapeutics Inc | 197,855,000.0 | 2,685,369,000.0 | 3,599,934,000.0 |
| PCVX Vaxcyte Inc | 1,050,189,000.0 | 2,213,865,000.0 | 3,559,746,000.0 |
| EXEL Exelixis Inc | 258,346,000.0 | 1,549,718,000.0 | 2,960,276,000.0 |
| RGEN Repligen Corp | 783,964,000.0 | 1,131,570,000.0 | 2,830,644,000.0 |
| TECH Bio-Techne Corp | 187,540,000.0 | 648,567,000.0 | 2,736,017,000.0 |
| CRSP CRISPR Therapeutics AG | 225,670,000.0 | 1,943,891,000.0 | 2,256,130,000.0 |
| ALKS Alkermes Plc | 396,293,000.0 | 1,564,178,000.0 | 2,155,291,000.0 |
| HALO Halozyme Therapeutics Inc | 154,318,000.0 | 1,126,976,000.0 | 2,118,030,000.0 |
| INSM Insmed Inc | 461,451,000.0 | 1,649,845,000.0 | 2,052,972,000.0 |
| LEGN Legend Biotech Corp | 459,277,000.0 | 1,350,037,000.0 | 1,735,825,000.0 |
| NVAX Novavax Inc | 573,630,000.0 | 1,103,680,000.0 | 1,712,483,000.0 |
| NEO Neogenomics Inc | 361,992,000.0 | 590,241,000.0 | 1,641,111,000.0 |
| RNA Avidity Biosciences Inc | 370,187,000.0 | 1,621,866,000.0 | 1,640,771,000.0 |
| CERT Certara Inc | 233,023,000.0 | 350,609,000.0 | 1,543,229,000.0 |
| GH Guardant Health Inc | 585,022,000.0 | 1,226,715,000.0 | 1,538,727,000.0 |
| RARE Ultragenyx Pharmaceutical Inc | 150,619,000.0 | 799,608,000.0 | 1,538,363,000.0 |
| VIR Vir Biotechnology Inc | 168,350,000.0 | 1,047,157,000.0 | 1,498,356,000.0 |
| DNA Ginkgo Bioworks Holdings Inc | 616,214,000.0 | 662,480,000.0 | 1,480,883,000.0 |
| EBS Emergent BioSolutions Inc | 149,900,000.0 | 661,400,000.0 | 1,477,800,000.0 |
| DNLI Denali Therapeutics Inc | 90,636,000.0 | 868,839,000.0 | 1,454,013,000.0 |
| CYTK Cytokinetics Inc | 46,888,000.0 | 1,018,601,000.0 | 1,436,060,000.0 |
| ABCL Abcellera Biologics Inc | 126,640,000.0 | 742,883,000.0 | 1,392,828,000.0 |
| ITCI Intra-Cellular Therapies Inc | 464,312,000.0 | 1,271,731,000.0 | 1,324,445,000.0 |
| ANIP ANI Pharmaceuticals Inc | 144,982,000.0 | 521,297,000.0 | 1,287,377,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 578,157,000.0 | 679,098,000.0 | 1,278,215,000.0 |
| HCM HUTCHMED (China) Ltd | 203,953,000.0 | 1,048,260,000.0 | 1,260,868,000.0 |
| RCUS Arcus Biosciences Inc | 201,000,000.0 | 1,127,000,000.0 | 1,252,000,000.0 |
| IDYA IDEAYA Biosciences Inc | 400,283,000.0 | 932,214,000.0 | 1,239,873,000.0 |
| ASND Ascendis Pharma A/S | 696,379,594.35 | 1,084,055,004.6 | 1,217,697,676.07 |
| BPMC Blueprint Medicines Corp | 89,356,000.0 | 854,848,000.0 | 1,199,649,000.0 |
| NUVL Nuvalent Inc | 369,244,000.0 | 1,179,675,000.0 | 1,188,858,000.0 |
| NTLA Intellia Therapeutics Inc | 120,495,000.0 | 710,902,000.0 | 1,173,351,000.0 |
| BEAM Beam Therapeutics Inc | 230,203,000.0 | 945,534,000.0 | 1,171,367,000.0 |
| ARVN Arvinas Inc | 85,200,000.0 | 1,149,500,000.0 | 1,167,100,000.0 |
| MYGN Myriad Genetics Inc | 99,900,000.0 | 293,200,000.0 | 1,081,300,000.0 |
| DVAX Dynavax Technologies Corp | 119,332,000.0 | 926,241,000.0 | 1,061,990,000.0 |
| KYMR Kymera Therapeutics Inc | 110,718,000.0 | 568,715,000.0 | 1,034,842,000.0 |
| BCYC Bicycle Therapeutics PLC | 890,862,000.0 | 966,194,000.0 | 996,746,000.0 |
| IOVA Iovance Biotherapeutics Inc | 164,186,000.0 | 498,578,000.0 | 991,115,000.0 |
| ZLAB Zai Lab Ltd | 616,086,000.0 | 860,549,000.0 | 985,346,000.0 |
| KRYS Krystal Biotech Inc | 373,966,000.0 | 713,164,000.0 | 982,318,000.0 |
| ACAD ACADIA Pharmaceuticals Inc | 155,149,000.0 | 788,284,000.0 | 976,868,000.0 |
| LGND Ligand Pharmaceuticals Inc | 63,619,000.0 | 309,388,000.0 | 954,866,000.0 |
| CVAC CureVac NV | 613,269,155.98 | 650,957,362.35 | 950,958,958.52 |
| VKTX Viking Therapeutics Inc | 50,347,000.0 | 936,649,000.0 | 937,888,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 387,367,000.0 | 522,405,000.0 | 928,135,000.0 |
| APLS Apellis Pharmaceuticals Inc | 396,864,000.0 | 833,897,000.0 | 901,866,000.0 |
| MRUS Merus NV | 432,998,000.0 | 666,276,000.0 | 844,676,000.0 |
| XENE Xenon Pharmaceuticals Inc | 87,621,000.0 | 659,639,000.0 | 835,901,000.0 |
| AUTL Autolus Therapeutics PLC | 657,067,000.0 | 718,114,000.0 | 827,490,000.0 |
| CLDX Celldex Therapeutics Inc | 36,399,000.0 | 778,842,000.0 | 823,179,000.0 |
| AKRO Akero Therapeutics Inc | 316,065,000.0 | 746,888,000.0 | 817,547,000.0 |
| FOLD Amicus Therapeutics Inc | 233,647,000.0 | 498,474,000.0 | 786,557,000.0 |
| VRDN Viridian Therapeutics Inc | 200,317,000.0 | 767,357,000.0 | 771,900,000.0 |
| ACLX Arcellx Inc | 161,846,000.0 | 587,301,000.0 | 764,909,000.0 |
| AMRN Amarin Corporation PLC | 156,944,000.0 | 650,216,000.0 | 750,615,000.0 |
| ITOS Iteos Therapeutics Inc | 123,744,000.0 | 544,875,000.0 | 723,077,000.0 |
| JANX Janux Therapeutics Inc | 26,754,000.0 | 666,321,000.0 | 695,019,000.0 |
| MESO Mesoblast Ltd | 62,563,000.0 | 86,463,000.0 | 669,153,000.0 |
| MIRM Mirum Pharmaceuticals Inc | 222,969,000.0 | 386,626,000.0 | 667,893,000.0 |
| CGEM Cullinan Therapeutics Inc | 102,085,000.0 | 592,039,000.0 | 653,254,000.0 |
| QURE Uniqure NV | 251,626,000.0 | 464,138,000.0 | 645,806,000.0 |
| VNDA Vanda Pharmaceuticals Inc | 100,497,000.0 | 432,387,000.0 | 645,115,000.0 |
| IMTX Immatics NV | 210,633,354.71 | 570,869,506.33 | 642,627,726.57 |
| TWST Twist Bioscience Corp | 226,316,000.0 | 346,776,000.0 | 614,323,000.0 |
| SWTX SpringWorks Therapeutics Inc | 84,456,000.0 | 435,111,000.0 | 608,878,000.0 |
| PTGX Protagonist Therapeutics Inc | 131,121,000.0 | 476,769,000.0 | 603,857,000.0 |
| DAWN Day One Biopharmaceuticals Inc | 422,765,000.0 | 580,996,000.0 | 600,807,000.0 |
| PRTA Prothena Corporation PLC | 519,262,000.0 | 534,984,000.0 | 595,254,000.0 |
| ALLO Allogene Therapeutics Inc | 51,239,000.0 | 304,415,000.0 | 589,120,000.0 |
| TGTX TG Therapeutics Inc | 195,822,000.0 | 574,069,000.0 | 586,014,000.0 |
| PRTC PureTech Health PLC | 308,478,000.0 | 508,810,000.0 | 579,950,000.0 |
| KROS Keros Therapeutics Inc | 530,684,000.0 | 552,046,000.0 | 579,271,000.0 |
| NUVB Nuvation Bio Inc | 30,036,000.0 | 564,985,000.0 | 571,579,000.0 |
| AXSM Axsome Therapeutics Inc | 327,341,000.0 | 479,113,000.0 | 561,458,000.0 |
| SANA Sana Biotechnology Inc | 126,996,000.0 | 210,149,000.0 | 559,392,000.0 |
| ADPT Adaptive Biotechnologies Corp | 38,084,000.0 | 308,345,000.0 | 558,506,000.0 |
| KNSA Kiniksa Pharmaceuticals Ltd | 97,376,000.0 | 311,301,000.0 | 555,298,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例